Jin Medical International (ZJYL) Equity Ratio (2022 - 2025)

Jin Medical International has disclosed Equity Ratio across 4 years of filings, most recently posting 0.06 for Q3 2025.

• Equity Ratio for Q3 2025 came in at 0.06, down 91.11% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.06 (down 84.72% YoY), and the FY2025 annual result was 0.06, down 91.11% from the prior year.
• Equity Ratio came in at 0.06 for Q3 2025 at Jin Medical International, down from 0.62 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.73 in Q3 2023 to a low of 0.06 in Q3 2025.
• The 4-year median for Equity Ratio is 0.68 (2022), against an average of 0.53.
• Across the five-year window, Equity Ratio rose 0.16% in 2023 and plunged 91.11% in 2025, its largest moves.
• Jin Medical International's Equity Ratio stood at 0.73 in 2022, then gained by 0.16% to 0.73 in 2023, then dropped by 14.46% to 0.62 in 2024, then slumped by 91.11% to 0.06 in 2025.
• The last three Equity Ratio figures came in at 0.06 (Q3 2025), 0.62 (Q3 2024), and 0.73 (Q3 2023), per Business Quant data.